According to the recent study the interventional cardiology and peripheral vascular device market is projected to reach an estimated $38.0 billion by 2030 from $25.9 billion in 2023, at a CAGR of 5.6% from 2024 to 2030. Growth in this market is primarily driven by growing elderly population, rise in prevalence of chronic diseases, and advancements in medical technology and research.
A more than 150 – page report is developed to understand trends, opportunities and forecast in interventional cardiology and peripheral vascular device market by type (interventional cardiology and peripheral vascular device), device (angioplasty balloons, angioplasty stents, angioplasty catheters, EVAR stent graft, IVC filter, embolic protection device, guidewires, arteriotomy closure device, intravascular ultrasound system, and synthetic surgical graft), end user (hospitals and ambulatory surgical centers), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that interventional cardiology and peripheral vascular devices is expected to witness significant growth over the forecast period because of new technology innovations and aging population.
Within global interventional cardiology and peripheral vascular device market, the largest segment by end user is projected to be hospitals due to the growing public-private partnerships to improve access to healthcare services along with rapid developments in healthcare infrastructure and improving access to healthcare services. These are the major driving factors for growth in this segment over the forecast period.
Download sample by clicking on interventional cardiology and peripheral vascular device market
APAC is expected to remain the largest region because it is a large pharmaceutical manufacturing base and it is witnessing increasing technological advancements in interventional cardiology and peripheral vascular devices.
APAC is expected to witness the highest growth rate over the forecast period due to the presence of a large pool of respiratory patients, increasing healthcare expenditure, rapidly developing healthcare infrastructure, rising per capita income, growing middle-class population, and growing prevalence of tobacco smoking in this region.
Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronics Public Limited Company, C. R. Bard, Inc., Cook Medical Inc., Terumo Corporation, Cardinal Health Inc are the major suppliers in the interventional cardiology and peripheral vascular device providers.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Automotive Digital Signal Controller Market
Automotive Dry Air Filter Market
Automotive Fuel Return Line Market
Comments on “Lucintel Forecasts Interventional Cardiology and Peripheral Vascular Device Market to Reach $38.3 billion by 2030”